Tsung-Yun Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tsung-Yun Liu has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Chin-Wen Chi
Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan
3 shared publications- Chin-Wen Chi
Institute of Pharmacology, National Yang‐Ming University, Taipei, Taiwan, Republic of China
3 shared publications Kuo-Wei Chang
Oral Biology, National Yang-Ming University, Taipei, Taiwan, ROC
3 shared publicationsKuo‐Wei Chang
School of Dentistry, National Yang-Ming University, Taipei, Taiwan
3 shared publicationsWing-Yiu Lui
Department of Surgery, Veterans General Hospital-Taipei, Taiwan, Republic of China
3 shared publicationsChin‐Wen Chi
Department of Medical Research & Education, Veterans General Hospital-Taipei, Taiwan
2 shared publications
Latest Publications
- Open Access
- 3 February 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (3) , 442
The Associations between Erythropoietic Response with Inflammation Markers and Perfluorinated Chemicals in Hemodialysis Patients
Erythropoiesis-stimulating agents (ESA) are used to treat anemia in hemodialysis (HD) patients. We investigated the role of inflammation and accumulation of environmental toxins (perfluorinated chemicals (PFCs), such as perfluorooctanoic acid and perfluorooctane sulfonate) in the erythropoietic response of HD patients who receive a fixed monthly continuous erythropoietin receptor activator (CERA) dosage. Forty-five patients underwent three successive phases of ESA treatment for two months each (phase one: 100 µg CERA once monthly; phase two: 50 µg CERA twice monthly; phase three: 100 µg CERA once monthly). Patient data were collected to determine the association of various factors with erythropoietic response (change in hematocrit). Liquid chromatography-tandem mass spectrometry was used to analyze perfluorinated chemicals. Twenty-eight patients exhibited a poor erythropoietic response that was significantly associated with: age > 80 years, initial hematocrit > 36%, glucose > 200 mg/dL, alanine aminotransferase > 21 U/L, c-reactive protein > 1 mg/dL, interleukin−6 > 10 ng/mL, lactate dehydrogenase ≤ 190 U/L, and chloride ≤ 93 mEq/L. There was also a borderline significant association between inflammation and PFCs, although PFCs failed to show any impact on ESA response. Age, glucose, chloride, liver function, and inflammation may be associated with cost-effective fixed CERA dosage administered at an increased frequency.
- 3 February 2023
- Published by MDPI AG in Healthcare
- Vol. 11 (3) , 442
Open AccessThe Associations between Erythropoietic Response with Inflammation Markers and Perfluorinated Chemicals in Hemodialysis Patients
Erythropoiesis-stimulating agents (ESA) are used to treat anemia in hemodialysis (HD) patients. We investigated the role of inflammation and accumulation of environmental toxins (perfluorinated chemicals (PFCs), such as perfluorooctanoic acid and perfluorooctane sulfonate) in the erythropoietic response of HD patients who receive a fixed monthly continuous erythropoietin receptor activator (CERA) dosage. Forty-five patients underwent three successive phases of ESA treatment for two months each (phase one: 100 µg CERA once monthly; phase two: 50 µg CERA twice monthly; phase three: 100 µg CERA once monthly). Patient data were collected to determine the association of various factors with erythropoietic response (change in hematocrit). Liquid chromatography-tandem mass spectrometry was used to analyze perfluorinated chemicals. Twenty-eight patients exhibited a poor erythropoietic response that was significantly associated with: age > 80 years, initial hematocrit > 36%, glucose > 200 mg/dL, alanine aminotransferase > 21 U/L, c-reactive protein > 1 mg/dL, interleukin−6 > 10 ng/mL, lactate dehydrogenase ≤ 190 U/L, and chloride ≤ 93 mEq/L. There was also a borderline significant association between inflammation and PFCs, although PFCs failed to show any impact on ESA response. Age, glucose, chloride, liver function, and inflammation may be associated with cost-effective fixed CERA dosage administered at an increased frequency.
- 1 August 2013
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 61, 243-248
Oxidative stress and increased formation of vasoconstricting F2-isoprostanes in patients with reversible cerebral vasoconstriction syndrome
- 1 August 2013
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 61, 243-248
Oxidative stress and increased formation of vasoconstricting F2-isoprostanes in patients with reversible cerebral vasoconstriction syndrome
- 7 March 2011
- Published by Wiley in Head & Neck
- Vol. 34 (2) , 245-253
Association between areca‐stimulated vimentin expression and the progression of head and neck cancers
Background Areca nut chewing is a common oral habit of Asians that is closely associated with the high incidence of head and neck carcinoma. The purpose of this study was to investigate the impacts of areca nut chewing on neoplastic process of head and neck carcinoma. Methods Head and neck carcinoma cells were treated with areca nut extract to perceive the phenotypic impacts. Tumor tissues were analyzed with immunohistochemistry (IHC) to understand the association between areca-associated molecular changes and clinical variables. Results Upon treatment with areca nut extract, carcinoma cells showed the increase of vimentin. The activation of extracellular signal-regulated kinase (ERK)/cyclooxygenase (COX)-2/prostaglandin (PGE)-2 cascade underlay the upregulation. These cells also exhibited the enhancement of migration and invasion. By knocking down COX-2 and vimentin expression, the increase of cell mobility was reversed. Tumor exhibiting extensive vimentin and/or COX-2 expression displayed a significantly worse disease-associated survival than contrast groups. Conclusion Areca-modulated vimentin expression enhanced the progression of head and neck carcinoma. © 2011 Wiley Periodicals, Inc. Head Neck, 2012
- 7 March 2011
- Published by Wiley in Head & Neck
- Vol. 34 (2) , 245-253
Association between areca‐stimulated vimentin expression and the progression of head and neck cancers
Background Areca nut chewing is a common oral habit of Asians that is closely associated with the high incidence of head and neck carcinoma. The purpose of this study was to investigate the impacts of areca nut chewing on neoplastic process of head and neck carcinoma. Methods Head and neck carcinoma cells were treated with areca nut extract to perceive the phenotypic impacts. Tumor tissues were analyzed with immunohistochemistry (IHC) to understand the association between areca-associated molecular changes and clinical variables. Results Upon treatment with areca nut extract, carcinoma cells showed the increase of vimentin. The activation of extracellular signal-regulated kinase (ERK)/cyclooxygenase (COX)-2/prostaglandin (PGE)-2 cascade underlay the upregulation. These cells also exhibited the enhancement of migration and invasion. By knocking down COX-2 and vimentin expression, the increase of cell mobility was reversed. Tumor exhibiting extensive vimentin and/or COX-2 expression displayed a significantly worse disease-associated survival than contrast groups. Conclusion Areca-modulated vimentin expression enhanced the progression of head and neck carcinoma. © 2011 Wiley Periodicals, Inc. Head Neck, 2012
- 19 January 2009
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 38 (2) , 206-213
Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation
Background: In Taiwan, it is well documented that cigarette smoking and areca nut chewing contribute to the risk of oral squamous cell carcinoma (OSCC). The role of phosphorylated Akt (p-Akt) in oral carcinogenesis induced by nicotine and alkaline environments was investigated. Method: Immunohistochemistry (IHC) was used to detect p-Akt expression in cancerous (n = 30) precancerous (n = 30), and normal mucosa tissues (n = 10). Western blotting was used to detect time-dependent induction of p-Akt by 100 μM nicotine in normal human bronchial epithelial cell (NHBE), normal human oral keratinocytes (NHOK), immortalized human epithelial cells (HaCaT) and OEC-M1 cells, dose-dependent induction of p-Akt in OEC-M1 and HaCaT cells and pH effect of p-Akt in OEC-M1. The unpaired t-test and the Fisher’s exact test were used to analyze the p-Akt immunoreactivity in various groups and its association with clinicopathological parameters. Results: Higher p-Akt expression in cancerous group than in normal mucosa (P = 0.0002) and precancerous (P = 0.0049) groups was observed. A time-dependent increase in p-Akt in the NHBE, NHOK, HaCaT and OEC-M1 cell lines was observed with 100 μM nicotine treatment. The dose-dependent increase in p-Akt by nicotine treatment in HaCaT and OEC-M1 cells was obviously observed. Higher p-Akt expression in more alkaline environment (pH 8.0) was observed than at pH 7.4 in OEC-M1 cells. Conclusion: A potential role for increased p-Akt may relate to the dose and time of nicotine use. The potential role of an alkaline environment to enhance nicotine-related oral carcinogenesis may exist.
- 19 January 2009
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 38 (2) , 206-213
Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation
Background: In Taiwan, it is well documented that cigarette smoking and areca nut chewing contribute to the risk of oral squamous cell carcinoma (OSCC). The role of phosphorylated Akt (p-Akt) in oral carcinogenesis induced by nicotine and alkaline environments was investigated. Method: Immunohistochemistry (IHC) was used to detect p-Akt expression in cancerous (n = 30) precancerous (n = 30), and normal mucosa tissues (n = 10). Western blotting was used to detect time-dependent induction of p-Akt by 100 μM nicotine in normal human bronchial epithelial cell (NHBE), normal human oral keratinocytes (NHOK), immortalized human epithelial cells (HaCaT) and OEC-M1 cells, dose-dependent induction of p-Akt in OEC-M1 and HaCaT cells and pH effect of p-Akt in OEC-M1. The unpaired t-test and the Fisher’s exact test were used to analyze the p-Akt immunoreactivity in various groups and its association with clinicopathological parameters. Results: Higher p-Akt expression in cancerous group than in normal mucosa (P = 0.0002) and precancerous (P = 0.0049) groups was observed. A time-dependent increase in p-Akt in the NHBE, NHOK, HaCaT and OEC-M1 cell lines was observed with 100 μM nicotine treatment. The dose-dependent increase in p-Akt by nicotine treatment in HaCaT and OEC-M1 cells was obviously observed. Higher p-Akt expression in more alkaline environment (pH 8.0) was observed than at pH 7.4 in OEC-M1 cells. Conclusion: A potential role for increased p-Akt may relate to the dose and time of nicotine use. The potential role of an alkaline environment to enhance nicotine-related oral carcinogenesis may exist.
- 1 March 2007
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 11 (1) , 77-84
Correlation between Platelet Amyloid Precursor Protein Isoform Ratio and Cognition in Alzheimer's Disease
This study analyzed whether platelet amyloid β-protein precursor (AβPP) isoform ratio correlates with cognition or cognitive decline in patients with Alzheimer's disease (AD). Platelet AβPP isoform ratio was measured, and cognitive assessment was per
- 1 March 2007
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 11 (1) , 77-84
Correlation between Platelet Amyloid Precursor Protein Isoform Ratio and Cognition in Alzheimer's Disease
This study analyzed whether platelet amyloid β-protein precursor (AβPP) isoform ratio correlates with cognition or cognitive decline in patients with Alzheimer's disease (AD). Platelet AβPP isoform ratio was measured, and cognitive assessment was per
- 20 January 2006
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 35 (2) , 99-103
The functional (−1171 5A→6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users
Background: Insertion/deletion (−1171 5A→6A) polymorphisms in the promoter region of matrix metalloproteinase 3 (MMP3) gene result in different transcriptional activities. MMP3 is able to degrade collagens types II, V, IX, and X, and other extracellular matrix. The functional promoter polymorphism of MMP3 has been related to the susceptibility in some inflammatory diseases and metastasis of cancers.Methods: Oral submucous fibrosis (OSF) and oral squamous cell carcinoma (OSCC) are prevalent among Asian areca users. In this study, genomic DNA obtained from the blood of OSCC (n = 150), OSF (n = 71), and control non‐diseased areca user (n = 98) in male were subjected to polymerase chain reaction (PCR)‐based genotyping of MMP3.Results: The 5A genotype in MMP3 promoter was observed more frequently in OSF group than in control group (P = 0.01). No significant difference was noted between OSCC and control groups on the 5A genotype frequency (P = 0.18). No association was found between 5A genotype in MMP3 promoter and site or lymph node metastasis and stage of OSCC.Conclusion: The results indicated that the 5A genotype of MMP3 promoter was associated with the risk of OSF but not OSCC.
- 20 January 2006
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 35 (2) , 99-103
The functional (−1171 5A→6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users
Background: Insertion/deletion (−1171 5A→6A) polymorphisms in the promoter region of matrix metalloproteinase 3 (MMP3) gene result in different transcriptional activities. MMP3 is able to degrade collagens types II, V, IX, and X, and other extracellular matrix. The functional promoter polymorphism of MMP3 has been related to the susceptibility in some inflammatory diseases and metastasis of cancers.Methods: Oral submucous fibrosis (OSF) and oral squamous cell carcinoma (OSCC) are prevalent among Asian areca users. In this study, genomic DNA obtained from the blood of OSCC (n = 150), OSF (n = 71), and control non‐diseased areca user (n = 98) in male were subjected to polymerase chain reaction (PCR)‐based genotyping of MMP3.Results: The 5A genotype in MMP3 promoter was observed more frequently in OSF group than in control group (P = 0.01). No significant difference was noted between OSCC and control groups on the 5A genotype frequency (P = 0.18). No association was found between 5A genotype in MMP3 promoter and site or lymph node metastasis and stage of OSCC.Conclusion: The results indicated that the 5A genotype of MMP3 promoter was associated with the risk of OSF but not OSCC.
- 25 September 2004
- Published by Elsevier in Toxicology Letters
- Vol. 152 (3) , 235-243
Hydroxychavicol modulates benzo[a]pyrene-induced genotoxicity through induction of dihydrodiol dehydrogenase
- 25 September 2004
- Published by Elsevier in Toxicology Letters
- Vol. 152 (3) , 235-243
Hydroxychavicol modulates benzo[a]pyrene-induced genotoxicity through induction of dihydrodiol dehydrogenase
- Open Access
- 20 May 2004
- Published by Wiley in International Journal of Cancer
- Vol. 111 (5) , 727-732
Increased expression of amyloid precursor protein in oral squamous cell carcinoma
In our previous study, we identified amyloid precursor protein (APP) in an oral squamous cell carcinoma (OSCC)‐enriching subtractive hybridization library. Our present study attempts to define the significance of APP expression in the genesis of OSCC. RT‐PCR analysis showed increase in APP mRNA expression for more than 2‐fold in 76% of OSCC (n = 55) relative to corresponding non‐cancerous matched tissues (NCMT). The majority of esophageal SCCs also had increase in APP mRNA expression. OSCC patients exhibiting increase in APP mRNA expression had significantly lower survival rate compared to patients exhibiting the opposite status. Western blotting analysis identified APP751 and APP770 as the major APP isoforms in oral keratinocytes. A high correlation between mRNA and protein expressions of APP was noted in OSCC/NCMT pairs. Immunohistochemistry further showed a remarkable increase of APP in OSCC tissue relative to NCMT. Treatment with an antisense oligonucleotide against APP reduced cellular and secreted APP as well as growth in an OSCC cell line. Our study provides novel clues that APP expression is involved in the proliferation and carcinogenesis of OSCC. Correlated with such pathogenesis was the survival of its victims. The degree of APP expression could serve as an invaluable marker for oral carcinogenesis.
- 20 May 2004
- Published by Wiley in International Journal of Cancer
- Vol. 111 (5) , 727-732
Open AccessIncreased expression of amyloid precursor protein in oral squamous cell carcinoma
In our previous study, we identified amyloid precursor protein (APP) in an oral squamous cell carcinoma (OSCC)‐enriching subtractive hybridization library. Our present study attempts to define the significance of APP expression in the genesis of OSCC. RT‐PCR analysis showed increase in APP mRNA expression for more than 2‐fold in 76% of OSCC (n = 55) relative to corresponding non‐cancerous matched tissues (NCMT). The majority of esophageal SCCs also had increase in APP mRNA expression. OSCC patients exhibiting increase in APP mRNA expression had significantly lower survival rate compared to patients exhibiting the opposite status. Western blotting analysis identified APP751 and APP770 as the major APP isoforms in oral keratinocytes. A high correlation between mRNA and protein expressions of APP was noted in OSCC/NCMT pairs. Immunohistochemistry further showed a remarkable increase of APP in OSCC tissue relative to NCMT. Treatment with an antisense oligonucleotide against APP reduced cellular and secreted APP as well as growth in an OSCC cell line. Our study provides novel clues that APP expression is involved in the proliferation and carcinogenesis of OSCC. Correlated with such pathogenesis was the survival of its victims. The degree of APP expression could serve as an invaluable marker for oral carcinogenesis.
- 9 September 2003
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 32 (9) , 522-529
Elevated expression of cyclooxygenase (COX)‐2 in oral squamous cell carcinoma – evidence for COX‐2 induction by areca quid ingredients in oral keratinocytes
Background: Elevated expression of cyclooxygenase (COX)‐2 has been demonstrated in several human cancers. Whether COX‐2 is up‐regulated in areca quid (AQ) related oral squamous cell carcinoma (OSCC) is unknown and the potential of AQ ingredients to induce COX‐2 expression has not been studied.Methods: COX‐2 expression was analyzed by immunohistochemistry and RT‐PCR in oral tissues. The COX‐2 mRNA and protein induction potential of AQ ingredients were analyzed by real‐time RT‐PCR and Western blotting in normal human oral keratinocyte (NHOK).Results: COX‐2 protein expression was significantly higher (P < 0.01) in OSCC (n = 27) as compared to their adjacent non‐cancerous matched tissue (NCMT). COX‐2 protein was nearly undetectable in control normal oral mucosa. The level of COX‐2 mRNA was markedly elevated in 63% (12/19) of OSCC compared to NCMT. Hydroxychavicol induced COX‐2 mRNA and protein expression in NHOK.Conclusions: COX‐2 protein as well as mRNA expression were significantly enhanced in OSCC as compared to NCMT. Hydroxychavicol, a unique ingredient in AQ, induced COX‐2 expression in NHOK, which highlighted early involvement of COX‐2 in AQ‐associated oral oncogenesis.
- 9 September 2003
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 32 (9) , 522-529
Elevated expression of cyclooxygenase (COX)‐2 in oral squamous cell carcinoma – evidence for COX‐2 induction by areca quid ingredients in oral keratinocytes
Background: Elevated expression of cyclooxygenase (COX)‐2 has been demonstrated in several human cancers. Whether COX‐2 is up‐regulated in areca quid (AQ) related oral squamous cell carcinoma (OSCC) is unknown and the potential of AQ ingredients to induce COX‐2 expression has not been studied.Methods: COX‐2 expression was analyzed by immunohistochemistry and RT‐PCR in oral tissues. The COX‐2 mRNA and protein induction potential of AQ ingredients were analyzed by real‐time RT‐PCR and Western blotting in normal human oral keratinocyte (NHOK).Results: COX‐2 protein expression was significantly higher (P < 0.01) in OSCC (n = 27) as compared to their adjacent non‐cancerous matched tissue (NCMT). COX‐2 protein was nearly undetectable in control normal oral mucosa. The level of COX‐2 mRNA was markedly elevated in 63% (12/19) of OSCC compared to NCMT. Hydroxychavicol induced COX‐2 mRNA and protein expression in NHOK.Conclusions: COX‐2 protein as well as mRNA expression were significantly enhanced in OSCC as compared to NCMT. Hydroxychavicol, a unique ingredient in AQ, induced COX‐2 expression in NHOK, which highlighted early involvement of COX‐2 in AQ‐associated oral oncogenesis.
- 4 July 2003
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 32 (7) , 399-407
Modulation of KGF-1 gene expression in oral fibroblasts by ripe areca nut extract
- 4 July 2003
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 32 (7) , 399-407
Modulation of KGF-1 gene expression in oral fibroblasts by ripe areca nut extract